Welcome to the 3rd ADC Toxicity Summit
“Toxicity is the killer of ADCs” and remains the primary challenge limiting ADC success in the clinic. From unpredictable off-target effects to non-translating toxicity profiles and dose-limiting toxicities, the industry must address key hurdles in preclinical models, patient selection, ADC design, and cross-disciplinary communication to accelerate the next wave of safer, more effective ADCs.
The 3rd ADC Toxicity Summit was the only industry-led event bringing together toxicology, pharmacology, translational science, and clinical development experts to accelerate bench-to-bedside-to-bench innovation by preventing, predicting, and mitigating toxicities to enhance ADC safety and clinical translation.
With insights from influential leaders such as AbbVie, AstraZeneca, Daiichi Sankyo, Genentech, Iksuda, J&J, MacroGenics and more, this was your opportunity for in-depth discussions and world class presentations on maximizing the translational relevance of in vivo and in vitro studies, mitigating toxicities to extend clinical dose escalations, optimizing dosing regimens, navigating regulatory expectations for toxicity models and more…
It's a very focused meeting with quality discussions from experts in the field!
Attendee from Takeda
Due to the intimate setting, it is a very good opportunity to get in contact with colleagues from the field. Everyone is very open to haring information and experience.
Attendee from Heidelberg Pharma
The workshop is exceptional and very educational. I like the small size a lot because it allows for more interactions and discussions. Then the quality of the speakers is also very good.
Attendee from Sutro Biopharma
Explore the 2025 Full Event Guide
- Preclinical and clinical insights to optimize the communication and translation of your findings from in vitro and in vivo through to the clinic and back
- 20+ expert speakers who spoke at the event, sharing their expertise in toxicology, preclinical and translational sciences, and more!
- World-class insights on toxicities such as ocular, liver, and lung toxicity
- Share easily with colleagues and decision-makers to mobilize interest
The 2025 Industry-Leading Speakers:
2025 Partners:
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.